Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus, SARS-CoV-2 test
Clinical narrative: I began having widespread fasciculations that lasted about 2 weeks; first dose (July 29Jul2021), second dose on 20Sep; The paresthesia did not get worse after the second dose; shooting pains; skin crawling sensation; Itching; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Sep2021 (Lot number: FE3592) at the age of 26 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: IBUPROFEN; MULTIVITAMIN [VITAMINS NOS]. Vaccination history included: Bnt26b2 (DOSE 1 Batch/Lot No: EN0158 Location of injection: Arm Right., Patient reported that the paresthesia spread to fingers, face, scalp and lower legs.), administration date: 29Jul2021, when the patient was 26 years old, for Covid-19 Immunization, reaction(s): "paresthesia, included tingling, pins/needles, feeling of water droplets on skin", "fatigue", "lightheadedness", "weakness", "itching", "shooting pains", "skin crawling sensation".  The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 20Sep2021, outcome "unknown", described as "first dose (July 29Jul2021), second dose on 20Sep"; MUSCLE CONTRACTIONS INVOLUNTARY (non-serious) with onset 04Oct2021, outcome "recovering", described as "I began having widespread fasciculations that lasted about 2 weeks"; PARAESTHESIA (non-serious) with onset 2021, outcome "recovering", described as "The paresthesia did not get worse after the second dose"; PRURITUS (non-serious) with onset 2021, outcome "recovering", described as "Itching"; PAIN (non-serious) with onset 2021, outcome "recovering", described as "shooting pains"; FORMICATION (non-serious) with onset 2021, outcome "recovering", described as "skin crawling sensation". The events "i began having widespread fasciculations that lasted about 2 weeks", "the paresthesia did not get worse after the second dose", "itching", "shooting pains" and "skin crawling sensation" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of muscle contractions involuntary, paraesthesia, pruritus, pain, formication.  Additional information: After 1 week of first dose of vaccination on 29Jul2021, patient experienced tingling and paresthesia began in bilateral feet (right worse than left) and notable fatigue, lightheadedness and weakness for about 4 weeks. Paresthesia increased in frequency and intensity over the several weeks. Feelings included tingling, pins/needles, itching, shooting pains, skin crawling sensation, feeling of water droplets on skin. Paresthesia spread to fingers, face, scalp and lower legs. PCP ran bloodwork including vitamin b12, vitamin d, TSH/T4, A1c; all resulted normal. Paresthesia began to subside after about 7 weeks. so the patient received the second dose on 20Sep2021. Two weeks after second dose, the patient began having widespread fasciculation that lasted about 2 weeks. Patient reported that the paresthesia did not get worse after the second dose. The fatigue, lightheadedness and weakness did not return after second dose. Overall symptoms are about 80% better at almost 14 weeks post first vaccine dose. The patient reported that she do not have any known allergies. The patient did not have covid prior to vaccination and tested negative to COVID, post vaccination.  Follow-up attempts are completed. No further information is expected.